UK Independent Finance Intelligence · Est. 2024
Updated daily Newsletter For business
Home Hub: Insurance Travel Insurance With High Blood Pressure UK 2026
Hub: Insurance

Travel Insurance With High Blood Pressure UK 2026

CT
Chandraketu Tripathi
Finance Editor, Kaeltripton
Published 11 May 2026
Last reviewed 11 May 2026
✓ Fact-checked
Travel Insurance With High Blood Pressure UK 2026

Photo by Immo Wegmann on Unsplash

Advertisement

TL;DR: High blood pressure (hypertension) is one of the most frequently declared conditions on UK travel insurance applications. Insurers assess whether it is controlled, current medication, and whether any associated conditions such as heart disease or stroke history are present. Well-controlled hypertension without complications is typically insurable at mainstream rates. Associated conditions must also be declared. Full declaration under the Consumer Insurance (Disclosure and Representations) Act 2012 is legally required.

KEY FACTS
  • NHS England data indicates that approximately one in three adults in the UK has high blood pressure, making hypertension one of the most common pre-existing conditions declared on travel insurance applications (nhs.uk).
  • The Consumer Insurance (Disclosure and Representations) Act 2012, at legislation.gov.uk, requires applicants to declare all relevant medical conditions accurately, including hypertension and its associated complications.
  • The FCA Consumer Duty (PS22/9, effective July 2023, fca.org.uk) requires insurers to ensure their products meet the needs of customers, including those with common conditions such as hypertension.
  • The ABI's signposting protocol requires any insurer unable to offer suitable cover for a declared condition to direct applicants to specialist providers (abi.org.uk).
  • The UK GHIC provides access to state healthcare in EU and EEA countries but does not cover repatriation or private hospital care, both of which may be needed if a hypertension-related event such as a stroke occurs abroad (nhsbsa.nhs.uk).

How Insurers Assess Hypertension and Associated Risk Factors

Hypertension is among the conditions that mainstream travel insurers encounter most frequently and, for many applicants, the assessment results in relatively limited impact on the policy terms. However, the assessment is not a simple formality. Insurers assess hypertension on the basis of how well it is controlled, whether the reading has been stable over the past 12 months, what medication is currently prescribed, and critically whether any associated conditions are present. Hypertension rarely presents in isolation in older travellers: it is frequently associated with coronary artery disease, previous heart attack, previous stroke or transient ischaemic attack (TIA), atrial fibrillation, peripheral vascular disease, diabetes, or chronic kidney disease. Each of these is a separate declarable condition that carries its own risk weighting in the underwriting assessment. An applicant with controlled hypertension and no associated conditions is typically assessed as low additional risk by mainstream insurers, and cover is often available at standard or near-standard pricing. The picture changes significantly if hypertension is accompanied by any of the associated conditions listed above. In those cases, the insurer's assessment reflects the combined risk, and premium loadings or exclusions may apply to the associated conditions even if hypertension itself is accepted at standard pricing. Applicants should not assume that declaring hypertension covers the cardiovascular consequences: each condition must be declared separately in response to each applicable screening question.

What Must Be Declared Alongside Hypertension

The Consumer Insurance (Disclosure and Representations) Act 2012 requires insurance applicants to take reasonable care not to misrepresent their medical history. For people with hypertension, the most significant non-disclosure risk is not failing to declare the blood pressure condition itself, but failing to declare the cardiovascular, renal, or neurological conditions that frequently accompany it. A traveller who declares hypertension but does not declare a previous TIA because they consider it a minor event is taking a significant risk. If a stroke or further TIA occurs abroad, and the insurer establishes that a previous TIA was known but undisclosed, the claim may be reduced to what the insurer would have paid had full disclosure been made, or in cases of deliberate non-disclosure, may be repudiated entirely. The Financial Ombudsman Service's guidance on non-disclosure confirms this framework. Similarly, atrial fibrillation associated with longstanding hypertension must be declared separately, as it is a significant independent risk factor for stroke and embolic events. Cholesterol-lowering medication such as statins is often used alongside antihypertensive therapy; if a screening question asks about cholesterol or lipid disorders, this must also be declared. Applicants who are unsure whether a condition or its treatment needs to be declared should err on the side of declaration. The worst outcome of declaring something unnecessary is a modest premium loading; the worst outcome of failing to declare something material is a void or reduced claim.

Cover Outcomes for Hypertension: From Standard to Specialist

The range of cover outcomes for travellers with hypertension reflects the spectrum from simple, well-controlled hypertension to hypertension complicated by significant cardiovascular history. For applicants with controlled hypertension and no associated conditions, many mainstream insurers offer cover at standard pricing, treating hypertension as a managed background condition rather than an active risk. For applicants with controlled hypertension alongside well-managed additional conditions, a premium loading reflecting those conditions is the most common outcome. For applicants with hypertension alongside significant history such as a recent myocardial infarction, a recent stroke, or unstable angina, mainstream insurers are more likely to apply exclusions or refer the applicant to specialist underwriters. Specialist medical travel insurers, accessible through the MoneyHelper directory at moneyhelper.org.uk or via BIBA at biba.org.uk, are able to assess complex cardiovascular risk profiles in more detail and often offer cover that includes hypertension-related emergencies such as a hypertensive crisis or stroke. The cost of an emergency stroke admission abroad, particularly outside the EU, can be very high, and cover that includes the declared hypertension and its associated conditions provides critical financial protection in this scenario. Applicants should always compare the scope of cover, specifically whether a hypertensive emergency, stroke, or cardiac event is included, not merely whether hypertension appears as a declared condition on the policy schedule.

Medication, Blood Pressure Monitoring and Travel Logistics

Practical preparation for travel with hypertension includes several considerations related to medication management and blood pressure monitoring. Travellers should carry sufficient antihypertensive medication for the full trip plus a contingency supply, keep medication in hand luggage to avoid temperature extremes in the hold, and carry a GP letter confirming the prescription if travelling to a destination with unfamiliar pharmacy systems. Long-haul flights, dehydration, altitude changes, and time zone disruptions can all affect blood pressure control. Some destinations, including high-altitude locations, present specific challenges for people with cardiovascular conditions. The FCDO's country-specific travel advice at gov.uk/foreign-travel-advice includes health information relevant to the destination, and consulting a GP or travel clinic before visiting high-altitude or high-heat destinations is advisable. For EU and EEA travel, the GHIC from nhsbsa.nhs.uk provides access to state hospital care in an emergency, but does not cover repatriation, which may be necessary if a cardiovascular event leaves the traveller unable to fly commercially. The combination of a GHIC and a travel insurance policy that includes all declared cardiovascular conditions provides the most comprehensive protection for hypertensive travellers in Europe.

Specialist Insurers and the Signposting Requirement for Hypertension

Where a mainstream insurer cannot offer suitable cover for a traveller with hypertension and associated cardiovascular conditions, the ABI's signposting requirement means the insurer must direct the applicant to specialist providers. Specialist medical travel insurers are experienced in underwriting cardiovascular risk profiles and can often offer policies that include coverage for hypertension-related emergencies, stroke, and cardiac events after a detailed application process. The MoneyHelper directory at moneyhelper.org.uk is the government-backed starting point for identifying these providers, and BIBA's find-a-broker service connects applicants with specialist medical travel insurance brokers. When applying through specialist insurers, applicants with hypertension should prepare detailed information on their blood pressure readings over the past 12 months, all current medications and doses, a list of all associated conditions and their treatment status, the outcome of the most recent cardiovascular review, and any procedures such as stenting, bypass surgery, or ablation that have taken place. This information enables accurate underwriting and reduces the risk of a dispute at claim stage. The FCA's Consumer Duty framework reinforces that insurers must ensure their products genuinely meet the needs of customers; travellers who feel they have been offered unsuitable cover, or who have been signposted to specialist providers without adequate guidance, can raise concerns through the FOS complaints process.

Editorial Disclaimer: Kaeltripton.com is an independent editorial publisher and is not authorised or regulated by the Financial Conduct Authority. Content is for informational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Always verify rates and product details with the relevant provider, the FCA register, HMRC or the Bank of England before any financial decision.

Frequently Asked Questions

Do I need to declare high blood pressure if it is controlled by medication?

Yes. Controlled hypertension is still a pre-existing condition that must be declared on a travel insurance application. The Consumer Insurance (Disclosure and Representations) Act 2012 requires applicants to answer screening questions accurately, and a question about cardiovascular conditions or blood pressure requires an honest answer regardless of how well the condition is managed. The impact on premium or cover terms will depend on the insurer's assessment of the full medical picture.

Do I need to declare my cholesterol medication alongside blood pressure?

Yes, if the screening questionnaire asks about cholesterol, lipid disorders, or cardiovascular medications. Statins and other cholesterol-lowering drugs are commonly prescribed alongside antihypertensives and their presence in the prescription list indicates an associated cardiovascular risk profile that the insurer needs to assess. Failing to declare associated conditions or medications carries the same non-disclosure risk as failing to declare the primary condition.

Will travel insurance cover a stroke abroad if I have high blood pressure?

Only if all relevant conditions including hypertension and any associated cardiovascular conditions were declared and included in the policy. A policy that excludes hypertension or cardiovascular disease will not cover stroke treatment costs. Given the potentially very high cost of stroke treatment and rehabilitation abroad, particularly in countries without reciprocal healthcare, ensuring all cardiovascular conditions are declared and covered is critically important before travelling.

Can I get travel insurance after a recent change in blood pressure medication?

A recent medication change is a factor that insurers consider in their stability assessment. It does not automatically prevent cover but may result in a higher premium or a requirement to wait a defined period before cover is available. Some insurers require a minimum stability period of one to three months following a medication change before they will include the condition. Specialist providers may offer more flexible underwriting in these circumstances.

The UK Global Health Insurance Card, available free from nhsbsa.nhs.uk, provides access to medically necessary state-provided healthcare in EU and EEA countries. For a hypertension-related emergency requiring hospital admission in Europe, the GHIC can cover state hospital treatment at local resident rates. However, it does not cover repatriation, private facilities, or cancellation, and is a supplement to rather than a substitute for travel insurance that includes all declared cardiovascular conditions.

How We Verified This Guide

This guide was researched against primary UK sources including NHS guidance on high blood pressure at nhs.uk, the Consumer Insurance (Disclosure and Representations) Act 2012 via legislation.gov.uk, the FCA Consumer Duty policy statement PS22/9 at fca.org.uk, the Financial Ombudsman Service's travel insurance and non-disclosure guidance at financial-ombudsman.org.uk, the MoneyHelper travel insurance directory at moneyhelper.org.uk, the ABI's medical conditions signposting guidance at abi.org.uk, and the NHS Business Services Authority GHIC pages at nhsbsa.nhs.uk. Last reviewed May 2026 by Chandraketu Tripathi, finance editor at Kaeltripton.

Sources

Advertisement

Editorial Disclaimer

The content on Kaeltripton.com is for informational and educational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Kaeltripton.com is not authorised or regulated by the Financial Conduct Authority (FCA) and is not a financial adviser, mortgage broker, insurance intermediary or investment firm. Nothing on this site should be construed as a personal recommendation. Rates, figures and product details are indicative only, subject to change without notice, and should always be verified directly with the relevant provider, HMRC, the FCA register, the Bank of England, Ofgem or other appropriate authority before any financial decision is made. Past performance is not a reliable indicator of future results. If you require regulated financial advice, please consult a qualified adviser authorised by the FCA.

CT
Chandraketu Tripathi
Finance Editor · Kaeltripton.com
Chandraketu (CK) Tripathi, founder and lead editor of Kael Tripton. 22 years in finance and marketing across 23 markets. Writes on UK personal finance, tax, mortgages, insurance, energy, and investing. Sources: HMRC, FCA, Ofgem, BoE, ONS.

Stay ahead of your money

Free UK finance guides, rate changes and money-saving tips — straight to your inbox. No spam, unsubscribe anytime.

Read More

Get Kael Tripton in your Google feed

⭐ Add as Preferred Source on Google